Skip to main content

Find Clinical Trials

Home
Conditions
Liver Diseases

Clinical trial condition

Liver Diseases

Explore clinical trials studying Liver Diseases. Study availability and eligibility vary by location and protocol.

8,408 public trials 1,309 recruiting studies

Refine in advanced search Browse all conditions

Liver Diseases trial results

Completed

Dose Effect Relationship of MTX and IBD

NCT03531593

Conditions: Digestive System Diseases, Fibrosis, Gastroenteritis, +9 more
Locations: Children's Mercy Hospital Kansas City, Missouri, United States

View Trial Details

Completed

A Study of Grazoprevir (MK-5172) in Hepatitis C-Infected Male Participants (MK-5172-004)

NCT00998985

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Not specified

View Trial Details

Completed

Safety, Pharmacokinetics and Pharmacodynamics of Elbasvir (MK-8742) in Hepatitis C Infected Males (MK-8742-002)

NCT01532973

Conditions: Digestive System Diseases, Hepatitis, Hepatitis, Viral, Human, +3 more
Locations: Not specified

View Trial Details

Completed

Hydroxytyrosol and Vitamin E in Pediatric NASH

NCT02842567

Conditions: Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations: Hepatometabolic Department, Bambino Gesù Children's Hospital Rome, Italy

View Trial Details

Completed

Race Adiposity Interactions Regulate Mechanisms Determining Insulin Sensitivity

NCT03043235

Conditions: Digestive System Diseases, Fat; Liver, Fatty Liver, +7 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

View Trial Details

Completed

Prevalence of Hepatitis c Virus Infection Among Rheumatological Patients

NCT03587714

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Assiut governorate Asyut, Egypt

View Trial Details

Completed

The Impact of Delayed Diagnosis of Alpha-1 Antitrypsin Deficiency

NCT03039335

Conditions: Alpha 1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations: Biocerna LLC Fulton, Maryland, United States

View Trial Details

Completed

An Open-label Comparative Efficacy and Safety Study of Algeron (Cepeginterferon Alfa-2b) in Treatment-naive Patients With Chronic Hepatitis C

NCT01889433

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Gomel Regional Clinical Hospital Homyel, Belarus

Vitebsk Regional Clinical Hospital Vitebsk, Belarus

Suyash Hospital Pvt. Ltd. Opposite M.G.M Medical College A.B. Road Indore, India

M V Hospital & Research Center Lucknow, India

View all 19 locations

View Trial Details

Completed

Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) 300mg in Chinese Subjects With Chronic Hepatitis B (CHB)

NCT01300234

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: GSK Investigational Site Guangzhou, Guangdong, China

GSK Investigational Site Guangzhou, Guangdong, China

GSK Investigational Site Guangzhou, Guangdong, China

GSK Investigational Site Wuhan, Hubei, China

View all 20 locations

View Trial Details

Completed

Short Duration Versus Standard Response-Guided Therapy With Boceprevir Combined With PegIntron and Ribavirin in Previously Untreated Non-Cirrhotic Asian Participants With Chronic HCV Genotype 1 (MK-3034-107)

NCT01945294

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details